ID   POLK KO homo MSH-
AC   CVCL_4W73
SY   Nalm-6-MSH-/TK+/-/POLK-/-
DR   cancercelllines; CVCL_4W73
DR   JCRB; JCRB1514
DR   Wikidata; Q54947730
RX   PubMed=24461735;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; 9183; POLK.
CC   Knockout cell: Method=Homologous recombination; HGNC; 11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; 50800; DUX4 + HGNC; 5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1514
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD96 ! Nalm-6-TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 15
//
RX   PubMed=24461735; DOI=10.1016/j.dnarep.2013.12.008;
RA   Sassa A., Suzuki T., Kanemaru Y., Niimi N., Fujimoto H., Katafuchi A.,
RA   Gruz P., Yasui M., Gupta R.C., Johnson F., Ohta T., Honma M.,
RA   Adachi N., Nohmi T.;
RT   "In vivo evidence that phenylalanine 171 acts as a molecular brake for
RT   translesion DNA synthesis across benzo[a]pyrene DNA adducts by human
RT   DNA polymerase kappa.";
RL   DNA Repair 15:21-28(2014).
//